Omeprazol Amarox (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Amarox, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children.

GNH USA supplies Omeprazol Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates. - NSAID‑associated ulcer prevention: lowers the risk of ulcer development in chronic NSAID users.

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea indicating possible colitis. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Bone fractures: increased risk with long‑term use. - Vitamin B12 deficiency: anemia or neuropathy with prolonged therapy. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing omeprazole, clinicians should consider several safety aspects.

- Assess renal and hepatic function: dose adjustment may be needed in impairment. - Review long‑term use: evaluate need after 8‑12 weeks to avoid unnecessary exposure. - Monitor for infections: prolonged acid suppression can increase risk of gastrointestinal infections. - Counsel on nutrient absorption: prolonged therapy may affect magnesium, calcium and vitamin B12 levels. - Avoid concomitant use with certain antivirals: may alter drug concentrations. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir and other protease inhibitors: decreased antiviral efficacy. - Methotrexate (high dose): increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Digoxin: may raise serum concentrations, necessitating dose review. - Diazepam: enhanced sedation, monitor for excessive CNS depression. - Phenytoin: altered metabolism, may require dose adjustment.